How were Cotinga Pharmaceuticals' earnings last quarter?

Cotinga Pharmaceuticals Inc. (OTCMKTS:COTQF) issued its earnings results on Wednesday, December, 18th. The company reported ($0.01) earnings per share for the quarter.

How do I buy shares of Cotinga Pharmaceuticals?

Shares of COTQF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:COTQF

Cotinga Pharmaceuticals (COTQF) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free COTQF Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Cotinga Pharmaceuticals alerts:

Ad Altimetry

I’m officially sounding the alarm.

AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.

Just click here to watch my full uncensored interview.

About Cotinga Pharmaceuticals Stock (OTCMKTS:COTQF)

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

Ad Altimetry

I’m officially sounding the alarm.

Just click here to watch my full uncensored interview.

COTQF Stock News Headlines

January 13, 2022 | nasdaq.com

Cotinga Pharmaceuticals Inc (COTQF)

See More Headlines

Receive COTQF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cotinga Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 12/18/2013
Today: 4/19/2024
Fiscal Year End: 4/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:COTQF
CUSIP: N/A
CIK: N/A
Web: coti.theyatesnetwork.com
Phone: (800) 798-8680
Fax: 519-858-5179
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Ms. Alison D. Silva MA (Age 45)
MS, CEO, President & Director
Comp: $405.22k
Dr. Richard T. Ho (Age 61)
Chief Scientific Officer
Comp: $238.12k
Mr. Victor Hugo C.M.A. (Age 54)
CPA, Chief Financial Officer
Mr. Paul Papi
Vice President of Investor Relations

Key Competitors

View All Competitors

COTQF Stock Analysis - Frequently Asked Questions

How were Cotinga Pharmaceuticals' earnings last quarter?: Cotinga Pharmaceuticals Inc. (OTCMKTS:COTQF) issued its earnings results on Wednesday, December, 18th. The company reported ($0.01) earnings per share for the quarter.
How do I buy shares of Cotinga Pharmaceuticals?: Shares of COTQF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:COTQF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial